In a constantly evolving pharmaceutical landscape, moving smoothly from development to commercial manufacturing is a major challenge. Service fragmentation, lack of integration, cost uncertainties… These hurdles can slow down your projects and increase risks.
🎥 Watch the replay to discover how Fareva, as a fully integrated CDMO, streamlines this critical transition with centralized project management, expert teams, and a comprehensive network from development to commercial production.
What you’ll learn:
- The limits of traditional approaches and how fragmentation impacts timelines and budgets
- The benefits of working with an integrated CDMO: Fareva’s 3 GMP pilot sites and 15 manufacturing sites
- Our core expertise: highly potent oral forms, sterile production, and biotechnology
- A real-life case study: accelerated transfer of an mRNA vaccine, showcasing responsiveness and technical know-how
👩⚕️ Meet our speakers:
Philippe Rampignon, VP Pharmaceutical Development & NPI
Aude Remond, Corporate Quality Assurance Director – Pharma & API
🎯 Who should watch?
Anyone looking to reduce risks, shorten timelines, and accelerate time-to-market with an integrated development-driven approach.
🔗 Watch the full replay here 👉https://youtu.be/IINi-HyTkuU